Annals of Oncology Advance Access originally published online on September 15, 2005
Annals of Oncology 2006 17(2):350; doi:10.1093/annonc/mdj008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 European Society for Medical Oncology
letter to the editor |
Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention
| The first 10% of the full text of this article appears below. |
Alopecia is one of the most common adverse events of chemotherapy and although it is not life threatening it can be psychologically devastating. In an effort to reduce chemotherapy-induced hair loss various preventive measurements, such as the scalp cooling technique, tourniquet and medications, have
Medical Oncology Department, Henry Dunant Hospital, Mesogion 107, Athens 11 526, Greece
* (E-mail: hecogiat@otenet.gr)
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. D Krueger, P. M West, M. Sargent, A. E Lodolce, and A S. Pickard Bisphosphonate-Induced Osteonecrosis of the Jaw Ann. Pharmacother., February 1, 2007; 41(2): 276 - 284. [Abstract] [Full Text] [PDF] |
||||
